DimetteRM, SproatHF, SayeghES. The classification of carcinoma of the urinary bladder associated with schistosomiasis and metaplasia. J Urol1956; 75: 4.
2.
ThomasJE, BassetMT, SigolaLB, TaylorP.Relationship between bladder cancer incidence, schistosoma hematobium infections and geographical region in Zimbabwe. Trans R Soc Med HYG1990; 84: 551–3.
3.
MangoudAM, EssaMH, Abdel NabiM, Bilharzial role in staging bladder carcinoma histopathologicaltransurethral sonography and computerized tomography. J Egypt Soc Parasitol1990; 20: 273–9.
4.
El-SaidW, Abdel FattahM, AfifiA, KhedrE.Schistosomiasis as a cause of renal failure among 333 dialysis patients. XXIVth annual congress of EDTA1987; 25.
5.
El-SaidW.Progress of dialysis in Egypt. Proc 5th annual congress of the Egypt Soc Nephrol1983; 11.
6.
SabbourMS, El-SaidW, Abou GabalI.A clinical and pathological study of schistosomal nephritis. Bull Wld Hlth Org1972; 47.
7.
SobhMA, MoustafaFE, el-HousseiniF, BastaMT, DeelderAM, GhoniemMA. Scistosomal specific nephropathy leading to end-stage renal failure. Kidney Int1987; 31: 1006–11.
8.
Mc CredieM, CoatesMS, FordJM, DisneyAR, StewartJH. Geographical distribution of cancers of the kidney and urinary tract and analgesic nephropathy in Australia and New Zealand. Aust N Z J Med1990; 20: 684–8, 694.
9.
YaqoobM, Mc ClellaudP, BellGM, AhmadR, BakranA.Bladder tumours in paraplegic patients on renal replacement therapy. Lancet1991; 338: 1554–5.
10.
DelahuntB, NacyJN, FergusonAF. Giant sclerosing leiomyoma of bladder presenting as chronic renal failure. Urology1991; 37: 270–2.
11.
NadawiAF, MostafaMH, O'connerPJ. Involvement of alkylating agents in schistosome-associated bladder cancer: the possible basic mechanisms of induction. Cancer Lett1992; 63: 171–88.
12.
TrickerAR, MostafaMH, SpiegelhalderB, PreussmannP.Urinary nitrite and N-nitroso compounds in bladder cancer patients with schistosomiasis (Bilharziasis). IARC Sci Publ1991; 105: 178–81.
13.
WishahiM, El-BazHG, ShakerZA. Association between HLA-A, B, C and DR antigens and clinical manifestations of schistosoma hematobium in the bladder. Eur Urol1989; 16: 138–43.
14.
RaziuddinS, ShettyS, IbrahimA.Soluble interleukin-2 receptor levels and immune activation in patients with schistosomiasis and carcinoma of the urinary bladder. Scand J Immunol1992; 35: 637–41.
15.
BadawiAF, MostafaMH, Aboul-AzmT, HaboubiNY, O'connorPJ, CooperDP. Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. Carcinogenesis1992; 13: 877–81.
16.
AnwarWA, RosinMP. Reduction in chromosomal damage in schistosomiasis patients after treatment with praziquantel. Mutat Res1993; 298: 179–85.
17.
CohenSM, JohanssonSL. Epidemiology and etiology of baldder cancer. Urol Clin North Am1992; 19: 421–8.
18.
MatasAJ, SimmonsRL, KjellstrandCM, BuselmeierTS, JohnsonTL, MajasianJS. Increased incidence of malignancy in uremic patients and its significance to transplantation. Transplant Proc1977; 9: 1137.
19.
GurlandHJ, BrunnerFPV, DehnH, HarlenH, ParsonsFM, ScharerK.Combined report on nephrology dialysis and transplantation in Europe III, 1972. Proc EDTA1973; 10: I vi–vii.
20.
MiachPJ, DawbornJK, XipellJ.Neoplasia in patients with CRF on long-term dialysis. Clin Nephrol1976; 5: 101–4.
21.
SlifkinRF, GoldbergJ, NeffMS, BarezA, MatooM, GuptaS.Malignancy in end-stage renal disease. Trans Am Soc Artif Inter Organs1977; 23: 34–9.
22.
KinlenLJ, EastwoodJB, KerrDNS, Cancer in patients receiving dialysis. Br Med J1980; 2: 1401.
23.
RoblesNR, CaleroR, RengelH, ValderrabanoF.Hemodialysis and cancer. Nephron1990; 54: 271–2.
24.
CurtisJR. Cancer and patients with endstage renal failure. Br Med J1982; 284: 69–70.
